Christian zu Jeddeloh

Impact Venture Capital Investor at Norrsken VC
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Stockholm, SE
Languages
  • Deutsch Native or bilingual proficiency
  • Englisch Full professional proficiency
  • Spanisch Professional working proficiency
  • Schwedisch Limited working proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Sweden
    • Venture Capital and Private Equity Principals
    • 1 - 100 Employee
    • Impact Venture Capital Investor
      • Oct 2022 - Present

      Norrsken VC is an early-stage investor in startups which are solving the world's greatest challenges while building massive businesses. Supporting impact entrepreneurs at the Seed/Series A stages. Norrsken VC is an early-stage investor in startups which are solving the world's greatest challenges while building massive businesses. Supporting impact entrepreneurs at the Seed/Series A stages.

    • Board Observer
      • Mar 2022 - Jul 2022

      Introspect develops digital therapeutics to work in combination with atai's therapeutic interventions. Introspect develops digital therapeutics to work in combination with atai's therapeutic interventions.

    • Pharmaceutical Manufacturing
    • Board Observer
      • May 2021 - Jul 2022

      Kures is a clinical-stage biopharmaceutical company developing novel MOR agonists. Kures is a clinical-stage biopharmaceutical company developing novel MOR agonists.

    • United States
    • Mental Health Care
    • 1 - 100 Employee
    • Board Observer
      • May 2021 - Jul 2022

      Psyber develops a BCI-enabled digital therapeutic. Psyber develops a BCI-enabled digital therapeutic.

    • Germany
    • Biotechnology Research
    • 1 - 100 Employee
    • Investments & Venture Management
      • Feb 2021 - Jul 2022

      atai Life Sciences is a German-based, internationally active biotech company investing in and acquiring promising therapeutics redefining how the world approaches, prevents, and heals mental health disorders. atai Life Sciences is a German-based, internationally active biotech company investing in and acquiring promising therapeutics redefining how the world approaches, prevents, and heals mental health disorders.

    • Netherlands
    • Venture Capital and Private Equity Principals
    • 100 - 200 Employee
    • Private Equity Research
      • Aug 2020 - Dec 2020

      Financial and commercial analyses of private companies and industries Financial and commercial analyses of private companies and industries

    • Switzerland
    • Financial Services
    • 700 & Above Employee
    • Sales & Trading
      • Jul 2020 - Aug 2020

      Rotations in Equities Trading and HY Credit Trading Rotations in Equities Trading and HY Credit Trading

    • Germany
    • Banking
    • 700 & Above Employee
    • Mergers & Acquisitions
      • Jun 2019 - Aug 2019

      Corporate Mergers & Acquisitions Corporate Mergers & Acquisitions

    • Germany
    • Financial Services
    • 700 & Above Employee
    • Asset Management
      • Jun 2018 - Sep 2018

      Multi Asset Portfolio Management Multi Asset Portfolio Management

Education

  • Frankfurt School of Finance & Management
    Bachelor of Science, Finance
    2017 - 2021
  • Harvard University
    Visiting Undergraduate Student, Economics and Computer Science
    2019 - 2019
  • MIT Sloan School of Management
    Cross-registration during exchange semester, Advanced Corporate Finance
    2019 - 2019
  • Tecnológico de Monterrey
    Visiting Undergraduate Student, Finance
    2019 - 2019
  • Liebfrauenschule Oldenburg
    Abitur
    2008 - 2016

Community

You need to have a working account to view this content. Click here to join now